Prelude Therapeutics Overview
Prelude Therapeutics Discounted Cash Flow
DCF Analysis for PRLD.
Get informed when a big investor buys or sells
+ FollowFair Value
$1.05
Current Fair Value
$1.05
↓ 76.4% Downside
Overvalued by 76.4% based on the discounted cash flow analysis.
Average Upside/Downside (Comparison Companies)
Fair Value vs. Stock Price History
Upside/Downside History
Upside/Downside Comparison